-
1 Comment
J. B. Chemicals & Pharmaceuticals Limited is currently in a long term uptrend where the price is trading 51.7% above its 200 day moving average.
From a valuation standpoint, the stock is 2.3% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 4.9.
J. B. Chemicals & Pharmaceuticals Limited's total revenue rose by 27.9% to $5B since the same quarter in the previous year.
Its net income has increased by 132.5% to $2B since the same quarter in the previous year.
Finally, its free cash flow fell by 56.9% to $732M since the same quarter in the previous year.
Based on the above factors, J. B. Chemicals & Pharmaceuticals Limited gets an overall score of 3/5.
| Exchange | NSE |
|---|---|
| CurrencyCode | INR |
| ISIN | INE572A01036 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| PE Ratio | 40.11 |
|---|---|
| Target Price | 2143 |
| Dividend Yield | 1.0% |
| Beta | -0.09 |
| Market Cap | 251B |
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company's API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides dosage forms, such as tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, cold rubs, eye drops, troches, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, it offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners; and contract manufacturing services. The company provides its products in gastroenterology, anti-infectives, wound care, neonatology and pediatrics, gynaecology, dental, vitamins and minerals, hypertension, diabetes, nephrology, respiratory, pain-analgesic, dermatology, antivirals, lozenges, and contrast media and radio diagnostic therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Mumbai, India.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for JBCHEPHARM.NSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
